VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the absence of a clinically relevant interaction
between telaprevir and raltegravir at steady-state.Telaprevir is being investigated for the
treatment of chronic hepatitis C virus infection, and raltegravir is used to treat HIV
infection.